Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
CTBP2 pseudogene 5 is a processed pseudogene, not encoding a functional protein. It is related in sequence to the CTBP2 gene, which encodes C-terminal binding protein 2—a transcriptional co-repressor involved in transcription regulation and implicated in cancer biology[7]. However, CTBP2P5 itself does not produce an active molecule and is not considered a direct therapeutic target, receptor, enzyme, transporter, or functional protein. CTBP2P5 is a pseudogene. Pseudogenes are typically non-functional sequences in the genome that are homologous to functional genes but contain mutations or truncations that prevent them from producing functional proteins. It is not a receptor, enzyme, transporter, or any molecule with established biological or therapeutic activity. There are no known drugs, disease associations, or mechanisms of action relevant to CTBP2P5. The functional protein CtBP2 (C-terminal binding protein 2) is a transcriptional corepressor implicated in cancer and cell regulation, but CTBP2P5 only shares sequence similarity and does not have similar activity[7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on CTBP2 pseudogene 5 (CTBP2P5).